相关实验视频

Updated: Jul 24, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

在膀癌中MTHFD家族的表达,预后值和免疫透

Bai Shu Zheng1, Shun De Wang2, Jun Yong Zhang1

  • 1Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.

Current cancer drug targets
|August 4, 2023
PubMed
概括

甲基酸酸脱酶 (MTHFD) 家族在膀癌中被上调,与预后不佳和晚期相对应. 这些MTHFD基因可能成为膀癌患者的关键生物标志物和治疗点.

关键词:
膀癌是一种癌症.在MTHFD家族中.生物信息学分析分析免疫透 免疫透是什么?预后标志物.预后标志物.预后标志物 预后标志物

更多相关视频

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...